Taia T. Wang, Ph.D.
Affiliations: | 2010 | Microbiology | Icahn School of Medicine at Mount Sinai, New York, NY, United States |
Area:
Microbiology Biology, Immunology, Virology BiologyGoogle:
"Taia Wang"Parents
Sign in to add mentorThomas Moran | grad student | 2010 | Mount Sinai School of Medicine | |
(Structural determinants of influenza virus neutralization.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mallajosyula V, Chakraborty S, Sola E, et al. (2024) Coupling antigens from multiple subtypes of influenza can broaden antibody and T cell responses. Science (New York, N.Y.). 386: 1389-1395 |
Chakraborty S, Cheng BY, Edwards DL, et al. (2024) Sialylated IgG induces the transcription factor REST in alveolar macrophages to protect against lung inflammation and severe influenza disease. Immunity |
Arunachalam PS, Feng Y, Ashraf U, et al. (2022) Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine. Science Translational Medicine. 14: eabq4130 |
Chakraborty S, Gonzalez JC, Sievers BL, et al. (2022) Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity. Science Translational Medicine. eabm7853 |
Sievers BL, Chakraborty S, Xue Y, et al. (2022) Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses. Science Translational Medicine. eabn7842 |
González JC, Wang TT. (2021) Illuminating the Fc dependence of SARS-CoV-2 neutralization. Immunity |
Chakraborty S, Gonzalez JC, Sievers BL, et al. (2021) Divergent early antibody responses define COVID-19 disease trajectories. Biorxiv : the Preprint Server For Biology |
Chakraborty S, Mallajosyula V, Tato CM, et al. (2021) SARS-CoV-2 vaccines in advanced clinical trials: where do we stand. Advanced Drug Delivery Reviews |
Röltgen K, Powell AE, Wirz OF, et al. (2020) Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Science Immunology. 5 |
Nielsen SCA, Yang F, Jackson KJL, et al. (2020) Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2. Cell Host & Microbe |